Prepare for your visit
Nicholas Meade
Hattiesburg, MS · NPI 1760986137
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$85.24
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 5 by amount.
- Merck Sharp & Dohme LLC $25.74
- Dexcom, INC. $18.87
- Clovis Oncology, INC. $16.52
- Novo Nordisk INC $12.18
- Astrazeneca Pharmaceuticals LP $11.93
Questions you might ask
- I saw Nicholas Meade listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/8804963/nicholas-meade